Sign inJoin waitlistJoin the waitlist

Amal Assa'ad

Associate Director · Cincinnati Children's Hospital Medical Center

Credentials: · · ·

History

Cincinnati Children's Hospital Medical Center
Present

Pediatric Otolaryngology
Cincinnati Children's Hospital Medical Center
1995–1996
Allergy and Immunology
Cincinnati Children's Hospital Medical Center
1993–1995
Wright State University Boonshoft School of Medicine
1988–1992
Allergy and Immunology
University of Texas Health Science Center at San Antonio
1985–1987
Ain Shams University, Cairo, Egypt
1974–1978

Research

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
Journal of Allergy and Clinical Immunology · 2010 · 1,058 citations
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel
Journal of Allergy and Clinical Immunology · 2010 · 1,030 citations
Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis
Journal of Clinical Investigation · 2006 · 728 citations

Ruchi Gupta
28 papers
Jonathan Spergel
26 papers
HS
Hugh Sampson
23 papers
Hemant Sharma
21 papers
Mahboobeh Mahdavinia
19 papers · 5 as a resident
Marc Rothenberg
19 papers
Sami Bahna
18 papers
Stacie Jones
18 papers
LS
Lynda Schneider
17 papers
Scott Sicherer
16 papers
Carina Venter
15 papers
Joshua Boyce
14 papers

Grants

Consortium of Food Allergy Research Clinical Research Center at Cincinnati Children's Hospital Medical Center (CoFAR-CRC:CCHMC)
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $1.1M · Cincinnati Childrens Hosp Med Ctr
2024–2031
Genetic Ancestry Differences in IgE- Mediated Peanut Allergy in African Americans
National Institute of Allergy and Infectious Diseases · R21
PI · $437.3K · Cincinnati Childrens Hosp Med Ctr
2021–2024

Clinical trials

Study of Oral Food Challenge Biomarkers (SAFER)
Site PI · Recruiting
National Institute of Allergy and Infectious Diseases (NIAID)
2026–2027
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2026–2029
Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children
Site PI · Unknown · Phase 2
DBV Technologies
2020–2024